期刊文献+

三种不同IL-15基因转染对NCI-H446肿瘤细胞凋亡的影响

Effects of three kinds of IL-15 gene transfection on apoptosis of NCI-H446 cell
下载PDF
导出
摘要 目的探讨不同形式IL-15基因转染对人小细胞肺癌细胞株NCI-H446细胞凋亡的影响。方法用构建的3种转染不同IL-15基因的NCI-H446细胞模型:原型(CIL-15)、成熟肽(CIL-15mp)及以IL-2信号肽替代IL-15信号肽的改型IL-15基因(CIL-2sp-IL-15mp),以野生株NCI-H446细胞(CW)为对照,流式细胞术检测细胞凋亡率及Fas蛋白表达。结果与CW相比,CIL-15、CIL-15mp和CIL-2sp-IL-15mp凋亡率及Fas蛋白表达依次增加(P<0.05或<0.01)。结论 3种IL-15基因转染均可致NCI-H446细胞凋亡率明显增加,强度依次为改型>成熟肽>原型;这种作用与增加NCI-H446细胞Fas蛋白的表达有关。 Objective To investigate the effect of three kinds of 1L-15 gene transfection on apoptosis of NCI-H446 cell. Methods The three kinds of NCI-H446 cell models were transfected respectively by IL-15 prototype gene, IL-15 mature peptide gene, IL-15 modified gene (CIL-2sp-IL-15 rap) in which the signal peptide of IL-15 was replaced with that of IL-2, and the three different kinds of IL-15 gene transfection models were regarded as experimental groups, besides,the wide NCI-H446 cells (Cw) were used as control group. The cell apoptosis rate and expression levels of Fas protein were detected by flow cytometry. Results As compared with those in control group, the cell apoptosis rate and expression levels of Fas protein were increased in CIL-15,CIL-15mp,CIL-2sp-IL-15mp in turn ( P 〈0. 05 or P 〈 0.01 ). Conclusion The three kinds of IL-15 genes transfection can result in obvious increase of apoptosis rate of NCI-H446 cell,and the increase intensity is in turn IL-15 modified gene 〉 mature peptide gene 〉 prototype gene,which may be correlated with the increase of the expression levels of Fas protein.
出处 《河北医药》 CAS 2014年第20期3049-3050,共2页 Hebei Medical Journal
关键词 IL-15 基因转染 肺癌细胞 细胞凋亡 FAS IL-15 gene transfection lung cancer cells apoptosis Fas
  • 相关文献

参考文献7

  • 1王智华,王润田,丁军颖,张征峥,邓郁青,王平.不同IL-15基因转染对NCI-H446肿瘤细胞增殖的影响[J].免疫学杂志,2006,22(6):639-641. 被引量:2
  • 2张征峥,王润田,王丽,刘维华,杨丽娟,王平,丁军颖.三种IL-15基因转染NCI-H446细胞模型的建立与鉴定[J].免疫学杂志,2005,21(4):331-333. 被引量:4
  • 3Yoshimuta T. Gene therapy for murine Lung cancer using an adenoviral vector expressing Interleukin-15. Kurume Med J ,2004,51:225-233.
  • 4Araki A, Hazama S, Yoshimura K, et al. Tumor Secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcino- ma via CD8 + T cells. Int J Mol Med,2004,14:571-576.
  • 5Kumar D, Zimpelmann J, Robertson S, et al. Tubular and interstitial cell apoptosis in the strep tozotoc in 2 diabetic rat kidney. Nephron Exp Neph- ro1,2004 ,96 :77-88.
  • 6Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas ( Apo-1/CD95 ) ligand : implieations for tumor immune escape. Science, 1996,274 : 1363-1366.
  • 7Owen-Sehaub LB, Radinsky R, Kruzel E, et al. Anti-Fas on nonhemato- poietie tumors:levels of Fas/APO-1 and bcl-2 are not predietive of bio- logieal resnonsiveness. Cancer Res. 1994.54,1580-1586.

二级参考文献19

  • 1张征峥,王润田,王丽,刘维华,杨丽娟,王平,丁军颖.三种IL-15基因转染NCI-H446细胞模型的建立与鉴定[J].免疫学杂志,2005,21(4):331-333. 被引量:4
  • 2丁军颖,王润田,张征峥,杨志强,韩志鹏,李铁民,邓郁青,王平.不同IL-15转染对NCI-H446HLA-Ⅰ和HLA-Ⅱ表达及NK敏感性的影响[J].免疫学杂志,2005,21(6):468-470. 被引量:3
  • 3黄培堂 王嘉玺 朱厚础 等译 J萨姆布鲁克 DW拉塞尔著.分子克隆实验指南[M].北京:北京科学出版社,2002.27-30.
  • 4Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor[ J]. Science, 1994,264(5 161 ): 965 -968.
  • 5Carson WE, Giri JG, Lindemann MJ, et al . Interleukin ( 1 5 ) is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor [ J ]. J Exp Med, 1994,180(4): 1 395 - 1 403.
  • 6Armitage RJ, Macduff BM, Eisenman J, et al. IL-15 has stimulatory activity for the induction or B cell proliferation and differentiation[J]. J Immunol, 1995, 154(2) :483 - 490.
  • 7Nishimura H, Hiromatsu K, Kobayashi N, et al. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection[J]. J Immumol, 1996, 156 (2): 663 -669.
  • 8Lewko WM, Smith TL, Bowman DJ, et al. Interleukin-15 and the growth of tumor derived activated T-cells[J]. Cancer Biother, 1995,10( 1 ): 13 - 20.
  • 9Bamford RN , DeFilippisAP , Azimi N , et al . The5 'untranslated region, signal peptide, and the coding sequenceof the carboxyl terminus of IL-15 participate in its multifaceted translational control [ J ]. J Immunol, 1998,160(9) :4 418 - 4 426.
  • 10Hazama S, Noma T, Wang F, et al. Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo [ J ]. Br J cancer, 1999,80(9):1 420- 1 426.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部